冠心病领域临床研究2023年度进展  

2023 clinical research inventory in the field of coronary heart disease

作　　者：刘耀琨 郑博[1] 霍勇[1] LIU Yao-kun;ZHENG Bo;HUO Yong(Department of Cardiology,Peking University First Hospital,Cardiovascular Disease Research Institute,Beijing 100034,China)

机构地区：[1]北京大学第一医院心内科心血管疾病研究所,北京100034

出　　处：《中国介入心脏病学杂志》2024年第1期24-31,共8页Chinese Journal of Interventional Cardiology

摘　　要：本文盘点总结2023年度冠心病领域重要临床研究进展。通过Web of Science网站,以“heart”“cardi*”“myocardi*”“coronary”“arrhythmi*”“valv*”“hypertension”等作为关键词,从顶级医学期刊中进行检索,最终筛选出引用较高且笔者认为对临床诊疗更具现实指导价值的论著,主要聚焦于腔内影像、血运重建策略、支架内再狭窄、抗血小板治疗以及血脂调控等方面。从提高和优化诊疗技术到新药研发,切实减轻全球冠心病负担。This review summarizes the progress of significant clinical studies in the field of coronary heart disease in 2023.The authors search from top-class medical journals on the Web of Science website,using‘heart’‘cardi*’‘myocardi*’‘coronary’‘arrhythmi*’‘valv*’‘hypertension’as keywords.Various original researches that are highly quoted and have much value for clinical guidance are finally screened out,mainly focusing on intravascular imaging,strategy of percutaneous coronary revascularization,in-stent restenosis,antiplatelet therapy,and lipid management.From optimizing technologies of diagnosis and treatment to developing new types of drugs,we hope the achievements could eff ectively reduce the global burden of coronary heart disease.

关 键 词：腔内影像 血运重建策略 支架内再狭窄 抗血小板治疗 血脂调控 

分 类 号：R54[医药卫生—心血管疾病]